Cargando…

Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation

BACKGROUND: In this study, we established and validated a model for predicting prognosis of stage IIA colon cancer patients based on expression profiles of aptamers in serum. METHODS: Bloods samples were collected from 227 consecutive patients with pathologic T3N0M0 (stage IIA) colon cancer. We incu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huh, Jung Wook, Kim, Sung Chun, Sohn, Insuk, Jung, Sin-Ho, Kim, Hee Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941318/ https://www.ncbi.nlm.nih.gov/pubmed/26908450 http://dx.doi.org/10.18632/oncotarget.7488

Ejemplares similares

Sample size calculation for microarray experiments with blocked one-way design
por: Jung, Sin-Ho, et al.
Publicado: (2009)

Statistical Issues in the Design and Analysis of nCounter Projects
por: Jung, Sin-Ho, et al.
Publicado: (2014)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

SNP Selection in Genome-Wide Association Studies via Penalized Support Vector Machine with MAX Test
por: Kim, Jinseog, et al.
Publicado: (2013)

A permutation-based multiple testing method for time-course microarray experiments
por: Sohn, Insuk, et al.
Publicado: (2009)

Robust test method for time-course microarray experiments
por: Sohn, Insuk, et al.
Publicado: (2010)

Array-based Discovery of Aptamer Pairs
por: Cho, Minseon, et al.
Publicado: (2014)

Prediction of a time-to-event trait using genome wide SNP data
por: Kim, Jinseog, et al.
Publicado: (2013)

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
por: Jeon, Chul-Hyo, et al.
Publicado: (2019)

Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer
por: Kim, Han-Gil, et al.
Publicado: (2021)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa
por: Villadiego-Sánchez, J.M., et al.
Publicado: (2009)

Comparison of Oncologic Outcomes Between Incomplete Obstructive Colon Cancer and Non-Obstructive Colon Cancer by Tumor Location
por: Lim, Ji Ha, et al.
Publicado: (2022)

Rejoinder: More Limitations of Bayesian Leave-One-Out Cross-Validation
por: Gronau, Quentin F., et al.
Publicado: (2019)

Limitations of Bayesian Leave-One-Out Cross-Validation for Model Selection
por: Gronau, Quentin F., et al.
Publicado: (2018)

Determining optimal neighborhood size for ecological studies using leave-one-out cross validation
por: Kim, Deok Ryun, et al.
Publicado: (2012)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Leaving out the Patient
Publicado: (1917)

An Iterative Leave-One-Out Approach to Outlier Detection in RNA-Seq Data
por: George, Nysia I., et al.
Publicado: (2015)

A case of type IIa early gastric cancer developed in pernicious anemia.
por: Ahn, M. J., et al.
Publicado: (1998)

A Stable Biotin-Streptavidin Surface Enables Multiplex, Label-Free Protein Detection by Aptamer and Aptamer-Protein Arrays Using Arrayed Imaging Reflectometry
por: Klose, Alanna M., et al.
Publicado: (2020)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Schwannoma of ascending colon treated by laparoscopic right hemicolectomy
por: Kim, Hun Jin, et al.
Publicado: (2012)

Is a cutoff value of 12 still useful in stage II right-sided colon cancer without risk factors?
por: Hwang, Jinseok, et al.
Publicado: (2022)

Aptamers for Anti-Viral Therapeutics and Diagnostics
por: Kim, Tae-Hyeong, et al.
Publicado: (2021)

Complete Remission of Unresectable Colon Cancer after Preoperative Chemotherapy Selected by Adenosine Triphosphate-Based Chemotherapy Response Assay
por: Huh, Jung Wook, et al.
Publicado: (2008)

Out-of-Plane Aptamer Functionalization of RNA Three-Helix Tiles
por: Chopra, Aradhana, et al.
Publicado: (2019)

Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells
por: Jung, Ji Hoon, et al.
Publicado: (2013)

Multiple testing for gene sets from microarray experiments
por: Sohn, Insuk, et al.
Publicado: (2011)

Therapeutic aptamers: developmental potential as anticancer drugs
por: Lee, Ji Won, et al.
Publicado: (2015)

Corrigendum to “Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells”
por: Jung, Ji Hoon, et al.
Publicado: (2018)

Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020)

Efficient strategies for leave-one-out cross validation for genomic best linear unbiased prediction
por: Cheng, Hao, et al.
Publicado: (2017)

Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
por: Akagi, Yoshito, et al.
Publicado: (2013)

Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions
por: Um, Jae Eun, et al.
Publicado: (2017)

Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature
por: Kim, Bongjune, et al.
Publicado: (2013)

Development of an aptamer-conjugated fluorescent nanoprobe for MMP2
por: Han, Myoung-Eun, et al.
Publicado: (2014)

Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis
por: Nam, Bo Young, et al.
Publicado: (2017)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease
por: Han, Zhongji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k0o3rr44s0t73fib8khjqatidr